| |
 |
|
Home > Pharmaceuticals & Biotechnology > Healthcare > Cancer Diagnostic Technologies: Assessment of Emerging Technologies and Market Applications
|
Cancer Diagnostic Technologies: Assessment of Emerging Technologies and Market Applications
|
 |
 |
 |
This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. Contains 110 pages
|
|
 |
| |
|
|
| |
|
|
|
Local PDF: $1850.00
Other Formats: Global PDF, Print
|
 |
| |
|
 |
| |
|
|
|